RNF4 negatively regulates NF-κB signaling by down-regulating TAB2.

Area of Science:

• Cellular signaling pathways
• Ubiquitination and post-translational modifications
• Immune response regulation

Background:

• Nuclear factor kappa B (NF-κB) signaling is crucial in immunity and inflammation.
• NF-κB pathway components undergo various post-translational modifications, including ubiquitination.
• Understanding these modifications is key to controlling NF-κB pathway activity.

Purpose of the Study:

• To identify novel regulators of the canonical NF-κB pathway.
• To investigate the role of ubiquitination in NF-κB signaling.
• To elucidate the mechanism by which RNF4 affects NF-κB activation.

Main Methods:

• Designed a siRNA library targeting ubiquitin-binding domains.
• Screened for regulators of canonical NF-κB pathway.
• Utilized overexpression and knockdown experiments for RNF4.
• Performed co-immunoprecipitation to study protein interactions.
• Investigated protein degradation pathways (lysosomal).

Main Results:

• Identified RNF4 as a regulator of the canonical NF-κB pathway.
• RNF4 overexpression inhibited NF-κB activation; RNF4 knockdown enhanced it.
• RNF4 interacts with TAK1-TAB2-TAB3 complex but not TAB1.
• RNF4 specifically down-regulates TAB2 via a lysosomal degradation pathway.
• RNF4 knockdown inhibited endogenous TAB2 degradation.

Conclusions:

• RNF4 acts as a negative regulator of the NF-κB signaling pathway.
• The mechanism involves RNF4-mediated lysosomal degradation of TAB2.
• Findings provide new insights into the post-translational regulation of NF-κB.